Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo D'Apuzzo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma PatientsJana Portnow, Timothy W Synold, Behnam Badie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E Brown, Behnam Badie, Michael E Barish, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Stem Cells Translational Medicine|September 10, 2013
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical useMargarita Gutova, Joseph A Frank, Massimo D'Apuzzo, et al.
Science Translational Medicine|May 10, 2013
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studiesKaren S Aboody, Joseph Najbauer, Marianne Z Metz, et al.
The New England Journal of Medicine|December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E Brown, Darya Alizadeh, Renate Starr, et al.
Neuro-Oncology|January 31, 2022
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastomaChristine E Brown, Analiz Rodriguez, Joycelynne Palmer, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma PatientsJana Portnow, Timothy W Synold, Behnam Badie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E Brown, Behnam Badie, Michael E Barish, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Stem Cells Translational Medicine|September 10, 2013
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical useMargarita Gutova, Joseph A Frank, Massimo D'Apuzzo, et al.
Science Translational Medicine|May 10, 2013
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studiesKaren S Aboody, Joseph Najbauer, Marianne Z Metz, et al.
The New England Journal of Medicine|December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E Brown, Darya Alizadeh, Renate Starr, et al.
Neuro-Oncology|January 31, 2022
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastomaChristine E Brown, Analiz Rodriguez, Joycelynne Palmer, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Pageof 5